Fig. 1From: Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancerConsort diagram. TAS: Target Analysis Set; mTAS: modified TAS; CT: Chemotherapy; RT: Radiotherapy; VAS: Visual Analogue Scale. *Some patients violated more than one criterionBack to article page